Literature DB >> 11795892

The neutrophil NADPH oxidase.

B M Babior1, J D Lambeth, W Nauseef.   

Abstract

The NADPH oxidase of phagocytes catalyzes the conversion of oxygen to O2(-). This multicomponent enzyme complex contains five essential protein components, two in the membrane and three in the cytosol. Unassembled and inactive in resting phagocytes, the oxidase becomes active after translocation of cytosolic components to the membrane to assemble a functional oxidase. Multiple factors regulate its assembly and activity, thus serving to maintain this highly reactive system under spatial and temporal control until recruited for antimicrobial or proinflammatory events. The recent identification of homologs of one of the membrane components in nonphagocytic cells will expand understanding of the biological contexts in which this system may function. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11795892     DOI: 10.1006/abbi.2001.2642

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  240 in total

Review 1.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

Review 2.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 3.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

4.  NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease.

Authors:  Monisha Dhiman; Nisha Jain Garg
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

5.  Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.

Authors:  Susan M E Smith; Jaeki Min; Thota Ganesh; Becky Diebold; Tsukasa Kawahara; Yerun Zhu; James McCoy; Aiming Sun; James P Snyder; Haian Fu; Yuhong Du; Iestyn Lewis; J David Lambeth
Journal:  Chem Biol       Date:  2012-06-22

6.  Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.

Authors:  James H Doroshow; Agnes Juhasz; Yun Ge; Susan Holbeck; Jiamo Lu; Smitha Antony; Yongzhong Wu; Guojian Jiang; Krishnendu Roy
Journal:  Biochem Pharmacol       Date:  2012-01-24       Impact factor: 5.858

7.  Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma.

Authors:  Nicole M Fletcher; Mohammed G Saed; Suleiman Abuanzeh; Husam M Abu-Soud; Ayman Al-Hendy; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

8.  NADPH oxidase-dependent formation of reactive oxygen species contributes to transforming growth factor β1-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells, and the role of astragalus intervention.

Authors:  Xiao-xian Liu; Hong-juan Zhou; Long Cai; Wen Zhang; Ji-lin Ma; Xiao-juan Tao; Jian-ning Yu
Journal:  Chin J Integr Med       Date:  2012-10-22       Impact factor: 1.978

9.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

Authors:  Ramon Bataller; Robert F Schwabe; Youkyung H Choi; Liu Yang; Yong Han Paik; Jeffrey Lindquist; Ting Qian; Robert Schoonhoven; Curt H Hagedorn; John J Lemasters; David A Brenner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 10.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.